UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:
September 6, 2024 4:01 P.M.
Form:
S-3
CIK:
0001738021
Company Name:
Compass Therapeutics, Inc.
File Number:
333-281891